Catalyst

Slingshot members are tracking this event:

Viking Therapeutics Announces Pricing of Public Offering of Common Stock and Warrants

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
VKTX

100%

Additional Information

Additional Relevant Details Viking Therapeutics announced the pricing of an underwritten public offering of 7,500,000 shares of its common stock and warrants to purchase up to 7,500,000 shares of its common stock at a public offering price of $1.25 per share of common stock and related warrant, for total expected gross proceeds to Viking of approximately $9,375,000, before deducting underwriting discounts, commissions, and other offering expenses. The warrants have an exercise price of $1.50 per share of common stock, are exercisable immediately and will expire five years from the date of issuance. Additionally, Viking has granted the underwriters a 45-day option to purchase up to an additional 1,125,000 shares of its common stock and/or warrants to purchase up to an additional 1,125,000 shares of its common stock to cover over-allotments, if any. All of the shares of common stock and warrants are being offered by Viking.
http://ir.vikingther...
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 08, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Public Offering